Article

Komen Greater NYC to Host Daylong Conference or Patients With Metastatic Breast Cancer at Pace University Featuring Renowned Breast Cancer Researchers and Clinicians

Author(s):

Susan G. Komen NYC

​A first of its kind in Westchester, this conference will provide patients, caregivers and medical professionals with critical information on treatments and living well with advanced breast cancer.

​Susan G. Komen Greater NYC will host the first annual Westchester Metastatic Breast Cancer Conference in conjunction with Pace University on Saturday, November 9, 2019, from 8:15 am to 3:15 pm at the ​Kessel Student Center, GottesmanRoom, PaceUniversity,​​8​ 61BedfordRoad, Pleasantville, NY10570.

The ​Westchester Metastatic Breast Cancer Conference​will provide patients living with stage IV/metastatic breast cancer with critical information on new and emerging treatments, integrative therapies and how to live well with advanced breast cancer. Attendees will enjoy a day of making connections, expanding resources, feeling empowered and being part of a caring community of breast cancer thrivers. ​Patrick Borgen, MD,​​Maimonides Medical Center, and Northwell Health, is Conference Chair.

The distinguished conference faculty includes​​Barry Boyd, MD,​Yale Health System, ​Chau Dang, MD,​​Memorial Sloan Kettering Cancer Center, Michelle C. Espinoza, MD,​​Northwell Health,​​Anna Komorowski, MD,​Northwell Health,​​Alice Police, MD,​​Northwell Health, ​Joseph Sparano, MD,​​Montefiore Medical Center, and ​Linda Vahdat, MD,​​Memorial Sloan Kettering Cancer Center.

Attendance is free.​​Advanced registration is required.​Register at k​omennyc.org/wmbcc.​

The Westchester Metastatic Breast Cancer Conference is made possible by ​​Amgen Oncology,​ Athenex Oncology,​​Genentech​​and ​Pace University.​

About Susan G. Komen Greater New York CityFounded in 1990, Susan G. Komen Greater NYC invests in medical research to find the cures and empowers a wide range of community-based programming to provide critical breast cancer services to medically underserved communities.Susan G. Komen NYC works to remove disparities in access to care to help ensure that where you live and the color of your skin does not determine whether you live. For more information, please visit​​www.komennyc.org.​

Related Videos
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Image of man with grey hair.
Image of woman with blonde hair.
Image of woman with brown hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of a woman with tied back hair, wearing pearl earrings.
Related Content
"FDA" text.
January 17th 2025

FDA Approves Datroway for HR+, HER2- Breast Cancer

Alex Biese
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of pills that spell "side FX"
January 15th 2025

Elinzanetant May Treat Hot Flashes Caused by Breast Cancer Treatment

Spencer Feldman
Elinzanetant significantly reduced the frequency and severity of hot flashes in women with breast cancer who were undergoing hormone therapy.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
An image of a doctor and patient talking with one another.
January 9th 2025

Minoxidil May Safely Aid in Hair Growth for Patients With Breast Cancer

Alex Biese
Low-dose oral minoxidil, the hair growth drug that is the active ingredient in Rogaine, may be safe and effective for patients with breast cancer.
An image of a doctor looking at a breast cancer scan.
January 7th 2025

CBD Use Found to Be Safe Among Patients with Breast Cancer, Prompts Further Study

Alex Biese
CBD consumption was safe but did not have a statistically significant reduction in scan-related anxiety versus placebo for patients with breast cancer.